Pioneers Memorial Healthcare District

Pioneers Memorial Healthcare District was paid $46.46M by Medicaid between Jan 2018 and Dec 2024, across 385 billing codes. Its largest line is 0450, Emergency room services — 11% of everything it billed.

33Billing provider infoPIONEERS MEMORIAL HEALTHCARE DISTRICT
BRAWLEY, CA 92227

33aNPI1073519443assigned 06/21/2005

33bProvider typeSkilled Nursing Facility

28Total paid$46.46M

24GClaims1,455,310

24DCodes billed385

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Skilled Nursing Facility providers in California

Rank by total paid#5 of 547

Median peer was paid$73K

This provider vs. median634×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	224,697	$6.29M
2019	237,236	$6.89M
2020	155,714	$4.41M
2021	188,652	$5.72M
2022	222,126	$7.97M
2023	243,201	$8.14M
2024incomplete	183,684	$7.03M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0450	Emergency room services	11%	92,433	80,461	$5.31M
74177	Computed tomography, abdomen and pelvis; with contrast material	5.4%	11,119	10,676	$2.50M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.7%	15,446	14,482	$2.16M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	3.7%	5,292	5,128	$1.71M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.5%	21,692	20,427	$1.62M
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	3.5%	11,311	11,014	$1.62M
93975		3.3%	6,652	6,410	$1.52M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	3.2%	17,428	16,534	$1.50M
80053	Comprehensive metabolic panel	2.5%	93,506	83,631	$1.18M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	2.5%	12,820	12,241	$1.14M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.5%	19,255	17,655	$1.14M
70450	Computed tomography, head or brain; without contrast material	2.4%	9,347	9,009	$1.11M

373 more codes

93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	2.3%	41,607	$1.09M
0122		1.8%	155	$849K
0259		1.8%	40,612	$820K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.7%	108,295	$773K
99499		1.6%	9,036	$744K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.5%	21,949	$696K
96375	Therapeutic injection; each additional sequential IV push	1.5%	18,054	$693K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.2%	7,773	$555K
96361	Intravenous infusion, hydration; each additional hour	1.2%	18,581	$544K
74176	Computed tomography, abdomen and pelvis; without contrast material	1.1%	4,653	$525K
72125	Computed tomography, cervical spine; without contrast material	1.1%	2,862	$500K
76705	Ultrasound, abdominal, real time with image documentation; limited	1.1%	7,895	$499K
0121		<1%	56	$434K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,071	$403K
J3490	Unclassified drugs	<1%	59,527	$359K
71046	Radiologic examination, chest; 2 views	<1%	16,200	$342K
84443	Thyroid stimulating hormone (TSH)	<1%	19,985	$332K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	5,137	$316K
71045	Radiologic examination, chest; single view	<1%	27,374	$306K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,674	$302K
J7030	Infusion, normal saline solution , 1000 cc	<1%	22,926	$302K
81001		<1%	34,753	$294K
0250		<1%	14,075	$283K
0762		<1%	421	$277K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,914	$271K
93970		<1%	1,456	$268K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	8,619	$248K
84484		<1%	27,968	$234K
83690		<1%	33,140	$230K
76819	Fetal biophysical profile; without non-stress testing	<1%	3,314	$214K
0761		<1%	4,931	$212K
80061	Lipid panel	<1%	19,088	$203K
76801		<1%	3,041	$202K
87486		<1%	5,295	$201K
Z7502		<1%	6,039	$196K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,822	$190K
76830	Ultrasound, transvaginal	<1%	2,659	$189K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	2,470	$184K
87581		<1%	5,297	$184K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,307	$173K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,780	$173K
76770		<1%	2,271	$170K
83036	Hemoglobin; glycosylated (A1C)	<1%	17,329	$168K
84480		<1%	10,591	$156K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	22,512	$144K
76641		<1%	1,962	$143K
93971		<1%	1,236	$141K
83880		<1%	5,225	$138K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	4,957	$137K
87086	Culture, bacterial; quantitative colony count, urine	<1%	17,845	$130K
36902		<1%	1,162	$128K
80048	Basic metabolic panel (calcium, ionized)	<1%	12,410	$124K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	548	$119K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	2,424	$117K
59025	Fetal non-stress test	<1%	3,547	$116K
93000		<1%	2,912	$115K
84439		<1%	12,466	$114K
73630		<1%	3,934	$113K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	3,052	$107K
73562		<1%	3,705	$106K
73130		<1%	2,995	$100K
70486		<1%	644	$99K
81025		<1%	9,170	$97K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	376	$97K
Z9725		<1%	3,212	$96K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,516	$95K
0636		<1%	10,734	$93K
0171	Inj, epinephrine (belcher)	<1%	64	$93K
73610		<1%	3,081	$91K
G0378	Hospital observation service, per hour	<1%	2,687	$91K
73030		<1%	3,019	$86K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	14,313	$84K
83605		<1%	7,456	$79K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,483	$76K
82607		<1%	5,447	$73K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,799	$73K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,647	$72K
82948		<1%	10,611	$70K
97139		<1%	1,942	$69K
72100		<1%	1,964	$68K
87040		<1%	4,844	$68K
36415	Collection of venous blood by venipuncture	<1%	23,151	$66K
73110		<1%	2,155	$66K
0361		<1%	429	$64K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	7,325	$63K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,036	$63K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,462	$62K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,234	$62K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,566	$61K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	1,233	$60K
70496		<1%	337	$59K
72110		<1%	1,263	$59K
87507		<1%	146	$58K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	7,481	$58K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	324	$58K
87186		<1%	6,573	$57K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,034	$56K
70498		<1%	362	$55K
85379		<1%	3,727	$54K
96367		<1%	1,396	$53K
86480		<1%	984	$50K
93976		<1%	246	$50K
86901		<1%	4,983	$49K
J7050	Infusion, normal saline solution, 250 cc	<1%	7,323	$48K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	5,654	$46K
73080		<1%	1,367	$44K
86850		<1%	2,816	$43K
90714		<1%	1,292	$43K
76870		<1%	703	$41K
E0114	Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips	<1%	881	$40K
74018		<1%	1,644	$40K
84702		<1%	2,597	$39K
87077		<1%	5,698	$39K
85730		<1%	6,906	$39K
71250		<1%	311	$38K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	868	$37K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,349	$36K
76604		<1%	778	$35K
10060		<1%	803	$35K
0710		<1%	1,565	$34K
86140		<1%	6,581	$34K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	5,731	$34K
80305		<1%	2,391	$34K
82550		<1%	5,106	$34K
72131		<1%	225	$33K
99221		<1%	29	$33K
77066	Tomosynthesis, mammo	<1%	297	$33K
85610		<1%	9,113	$32K
73590		<1%	1,086	$32K
86803		<1%	2,090	$31K
82803		<1%	2,414	$31K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	1,192	$30K
76775		<1%	731	$29K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	914	$28K
73090		<1%	849	$28K
29125		<1%	670	$28K
51701		<1%	589	$28K
0272		<1%	2,139	$27K
84153		<1%	1,603	$26K
82728		<1%	2,333	$26K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,756	$25K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	113	$25K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	813	$25K
84145		<1%	1,351	$23K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	833	$23K
0270		<1%	2,081	$22K
83735		<1%	3,692	$22K
A4217	Sterile water/saline, 500 ml	<1%	1,560	$22K
87451		<1%	3,269	$21K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	2,417	$21K
11043		<1%	344	$20K
87340		<1%	1,903	$20K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	3,063	$20K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	840	$20K
80076		<1%	2,808	$20K
86701		<1%	1,363	$19K
0258		<1%	603	$19K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	117	$19K
84466		<1%	1,495	$18K
82652		<1%	716	$18K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	39	$17K
12001		<1%	251	$17K
90715		<1%	438	$17K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,708	$16K
81002		<1%	6,316	$16K
0271		<1%	1,392	$16K
73140		<1%	614	$16K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	269	$16K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,262	$16K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	37	$15K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	2,345	$15K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,090	$14K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	729	$14K
80306		<1%	860	$14K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	89	$14K
86705		<1%	1,126	$13K
80074		<1%	213	$13K
86709		<1%	1,118	$13K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,454	$12K
85652		<1%	4,890	$12K
83540		<1%	2,258	$12K
99152		<1%	1,308	$12K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	1,440	$12K
0750		<1%	81	$11K
86308		<1%	1,232	$11K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	196	$10K
73503		<1%	246	$10K
83655		<1%	1,123	$10K
82570		<1%	2,515	$10K
87205		<1%	2,569	$10K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	1,286	$10K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	2,787	$10K
72040		<1%	283	$10K
87070		<1%	1,254	$9K
77080		<1%	326	$9K
86900		<1%	3,159	$9K
A9270	Non-covered item or service	<1%	3,057	$9K
84550		<1%	2,270	$9K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	44	$9K
76882		<1%	563	$9K
97750		<1%	123	$9K
84403		<1%	513	$9K
86920		<1%	95	$8K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	24	$8K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,353	$8K
86787		<1%	229	$8K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	168	$8K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	687	$8K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	27	$8K
76881		<1%	151	$8K
82553		<1%	682	$7K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	2,875	$7K
0360		<1%	42	$7K
84100		<1%	1,843	$7K
86592		<1%	1,680	$7K
76536		<1%	121	$7K
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	499	$7K
84703		<1%	738	$7K
73564		<1%	198	$7K
12011		<1%	80	$6K
86677		<1%	387	$6K
Q3014	Telehealth originating site facility fee	<1%	861	$6K
72050		<1%	142	$6K
82043		<1%	1,153	$6K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	196	$5K
Z7610		<1%	739	$5K
J1756	Injection, iron sucrose, 1 mg	<1%	81	$5K
52000		<1%	65	$5K
86038		<1%	702	$5K
J1815	Injection, insulin, per 5 units	<1%	533	$5K
99214	Doctor's office visit, returning patient (more involved)	<1%	89	$5K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	127	$5K
29515		<1%	79	$5K
72072		<1%	140	$5K
84156		<1%	1,454	$4K
82670		<1%	221	$4K
83550		<1%	681	$4K
83615		<1%	714	$4K
0637		<1%	346	$4K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	51	$4K
29530		<1%	174	$4K
73502		<1%	132	$4K
82009		<1%	685	$4K
G9012	Other specified case management service not elsewhere classified	<1%	50	$3K
96376		<1%	1,074	$3K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	12	$3K
36430		<1%	13	$3K
82040		<1%	35	$3K
85018		<1%	1,387	$3K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	803	$3K
85027		<1%	479	$3K
74178		<1%	15	$3K
85014		<1%	1,267	$3K
70491		<1%	12	$3K
84270		<1%	187	$3K
J2704	Injection, propofol, 10 mg	<1%	343	$3K
86762		<1%	193	$3K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	178	$3K
93017		<1%	52	$3K
29540		<1%	243	$3K
87081		<1%	92	$2K
99215	Doctor's office visit, returning patient (complex)	<1%	28	$2K
99213	Doctor's office visit, returning patient (routine)	<1%	68	$2K
77065	Tomosynthesis, mammo	<1%	25	$2K
77062		<1%	89	$2K
29105		<1%	13	$2K
83918		<1%	105	$2K
73060		<1%	89	$2K
87420		<1%	462	$2K
S0164	Injection, pantoprazole sodium, 40 mg	<1%	111	$2K
J0690	Injection, cefazolin sodium, 500 mg	<1%	223	$2K
70360		<1%	52	$2K
96368		<1%	86	$2K
82140		<1%	133	$2K
J1790	Injection, droperidol, up to 5 mg	<1%	218	$2K
J3360	Injection, diazepam, up to 5 mg	<1%	86	$2K
0300		<1%	588	$2K
0274		<1%	145	$1K
J1644	Injection, heparin sodium, per 1000 units	<1%	226	$1K
J8540	Dexamethasone, oral, 0.25 mg	<1%	339	$1K
0370		<1%	151	$1K
87045		<1%	142	$1K
51702		<1%	14	$1K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	222	$1K
83001		<1%	151	$1K
73552		<1%	54	$1K
J3370	Injection, vancomycin hcl, 500 mg	<1%	102	$1K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	218	$1K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	187	$1K
86200		<1%	144	$1K
87220		<1%	234	$1K
80081		<1%	13	$1K
80069		<1%	243	$984.60
82746		<1%	86	$930.77
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	89	$896.00
82247		<1%	161	$892.35
36600		<1%	53	$867.65
87210		<1%	225	$859.38
83002		<1%	93	$836.94
82010		<1%	96	$817.57
93880		<1%	13	$814.44
88304		<1%	76	$780.91
87015		<1%	110	$738.56
87899		<1%	133	$734.74
83525		<1%	76	$733.38
87075		<1%	134	$710.34
87450		<1%	129	$687.78
J1630	Injection, haloperidol, up to 5 mg	<1%	120	$642.26
82330		<1%	47	$637.91
83970		<1%	59	$631.57
73560		<1%	37	$631.14
87324		<1%	53	$536.78
74019		<1%	26	$533.13
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	85	$434.58
76857		<1%	12	$432.90
86430		<1%	71	$432.46
82150		<1%	63	$431.05
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	27	$414.50
87521	Neg quan hep c or qual rna	<1%	13	$393.80
J2550	Injection, promethazine hcl, up to 50 mg	<1%	51	$393.19
83874		<1%	32	$379.23
96523		<1%	49	$375.87
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	269	$372.65
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	787	$315.46
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	31	$305.09
J7510	Prednisolone oral, per 5 mg	<1%	63	$293.50
86738		<1%	19	$277.98
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	29	$265.91
84154		<1%	42	$261.00
73660		<1%	15	$257.58
17250		<1%	17	$246.20
C1769	Guide wire	<1%	536	$240.00
99153	Mod sedat endo service >5yrs	<1%	100	$231.78
83520		<1%	12	$212.63
C9290	Injection, bupivacaine liposome, 1 mg	<1%	36	$200.95
J1650	Injection, enoxaparin sodium, 10 mg	<1%	47	$192.72
J1940	Injection, furosemide, up to 20 mg	<1%	84	$190.72
86696		<1%	12	$164.04
86695		<1%	12	$164.04
72170		<1%	14	$161.66
76000		<1%	13	$139.56
80051		<1%	32	$130.88
0402		<1%	74	$130.47
82105		<1%	13	$129.90
86317		<1%	12	$126.01
82947		<1%	24	$112.08
82270		<1%	28	$94.31
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	12	$87.38
87147		<1%	15	$78.29
J2060	Injection, lorazepam, 2 mg	<1%	15	$75.86
81015		<1%	1,245	$70.60
0301		<1%	473	$63.06
82248		<1%	13	$54.82
J1171	Injection, hydromorphone, 0.1 mg	<1%	12	$44.92
0306		<1%	245	$41.67
0730		<1%	71	$29.84
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	34	$21.04
0324		<1%	70	$18.13
80197		<1%	14	$16.48
0278		<1%	12	$14.34
0305		<1%	421	$11.24
85007		0%	127	$0.00
0258R		0%	91	$0.00
0270R		0%	695	$0.00
0272R		0%	694	$0.00
0710R		0%	270	$0.00
0480		0%	12	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	69	$0.00
0370R		0%	41	$0.00
0720		0%	111	$0.00
0250R		0%	1,039	$0.00
80329		0%	13	$0.00
80320		0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLOPER, CARLY (CHIEF FINANCIAL OFFICER)